EBV EBNA-1 IgG ELISA Kit (Epstein–Barr Nuclear Antigen 1)

Full Name: EBV EBNA-1 IgG ELISA Kit (Epstein–Barr Nuclear Antigen 1)
Reactivity: Human
Sample Type: Plasma, Serum
Sensitivity: 1.64 U/ml


Epstein–Barr nuclear antigen 1 (EBNA1) is a dimeric and multifunctional viral protein which is linked to Epstein–Barr virus (EBV), it also has an vital function in maintaining and establishing the altered state the cells undertake following infection by EBV. EBNA1 contains a repeat sequence of glycine–alanine which separates the protein into the carboxy and amino-terminal domains. Another role of this sequence is in stabilising the protein and preventing proteasomal breakdown, in addition to impairing MHC class I-restricted antigen presentation and antigen processing.

It is the only latent protein-encoding genes that is identified to be consistently expressed in Burkitt’s lymphoma cells, this contributes to EBV malignancies via B cell-directed expression. There have many publications which indicate another important role of EBNA1 is in maintaining the function in tumors. There has also been recent associations to epithelial to mesenchymal transition (EMT) within nasopharyngeal carcinoma cells and this is through the TGF-β1/miR-200/ZEB signalling pathway.


Human EBV EBNA-1 IgG ELISA kit is designed for measuring in-vitro concentrations of human IgG antibodies to Epstein–Barr virus EBNA-1 (EBV EBNA-1 IgG) using serum or plasma. This assay has a minimum analytical sensitivity limit of 1.64 U/ml.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • EBV EBNA-1 coated microtiter strips.
  • Calibrator A (Negative Control).
  • Calibrator D (Positive Control).
  • Calibrator B (Cut-Off Standard).
  • Calibrator C (Weak Positive Control).
  • Sample Diluent.
  • Enzyme Conjugate.
  • TMB Substrate.
  • Washing Buffer (10x).
  • Stop Solution.


The minimum detection sensitivity level of human IgG antibodies against Epstein–Barr virus EBNA-1 (EBV-EBNA-1 IgG) using current EBV EBNA-1 IgG ELISA kit was 1.64 U/ml. The dynamic range for this assay is 1.0 – 150.0 U/ml.


– Intra-Assay-Precision: 7.6 %
– Inter-Assay-Precision: 6.6 %
– Inter-Lot-Precision: –
– Analytical Sensitivity: 1.6 U/mL
– Recovery: 77 – 83 %
– Linearity: 96 – 187 %
– Cross-Reactivity: No cross-reactivity to Cytomegaly, Herpes and Varicella.
– Interferences: No interferences to bilirubin up to 0.3 mg/mL, hemoglobin up to 8.0 mg/mL and triglycerides up to 5.0 mg/mL.
– Clinical Specificity: 97 %
– Clinical Sensitivity: 97 %


  1. High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis. Eur J Neurol. (2012) 19 (6): 842-6. Csuka D., et al.
  2. Evaluation of a new ELISA for the detection of specific IgG to the Epstein-Barr_nuclear antigen 1 (EBNA-1). Clin Lab. (2007) 53 (3-4): 151-5. Schenk B.I., et al.
  3. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn Microbiol Infect Dis. (2011) 70 (1): 85-90. Villegas E., et al.
  4. Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers. J Med Virol. (2013) 85 (1): 128-31. Dobson R., et al.


Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford